These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8234544)

  • 21. Self-awarensss in schizophrenia: its relationship to depressive symptomatology and broad psychiatric impairments.
    Schwartz RC
    J Nerv Ment Dis; 2001 Jun; 189(6):401-3. PubMed ID: 11434643
    [No Abstract]   [Full Text] [Related]  

  • 22. Denial of illness in schizophrenia as a disturbance of self-reflection, self-perception and insight.
    Bedford NJ; David AS
    Schizophr Res; 2014 Jan; 152(1):89-96. PubMed ID: 23890596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insight Into Illness and Defense Styles in Schizophrenia.
    Ogawa Y; Fukuhara K; Tanaka H; Nagata Y; Ishimaru D; Nishikawa T
    J Nerv Ment Dis; 2019 Oct; 207(10):815-819. PubMed ID: 31503176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coping and cognition in schizophrenia and depression.
    van den Bosch RJ; Rombouts RP
    Compr Psychiatry; 1997; 38(6):341-4. PubMed ID: 9406740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Resistant schizophrenia. Definition of a clinical approach and therapeutic strategy. Nosologic consequences for the concept of schizophrenia].
    Jalenques I; Coudert AJ; Porot M
    Ann Med Psychol (Paris); 1993 Apr; 151(4):354-6. PubMed ID: 8285507
    [No Abstract]   [Full Text] [Related]  

  • 26. Awareness of illness in schizophrenia and outpatient treatment adherence.
    Cuffel BJ; Alford J; Fischer EP; Owen RR
    J Nerv Ment Dis; 1996 Nov; 184(11):653-9. PubMed ID: 8955677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight dimensions and cognitive function in psychosis: a longitudinal study.
    Cuesta MJ; Peralta V; Zarzuela A; Zandio M
    BMC Psychiatry; 2006 May; 6():26. PubMed ID: 16737523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of illness in schizophrenia and schizoaffective and mood disorders.
    Amador XF; Flaum M; Andreasen NC; Strauss DH; Yale SA; Clark SC; Gorman JM
    Arch Gen Psychiatry; 1994 Oct; 51(10):826-36. PubMed ID: 7944872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopathological dimensions and lack of insight in schizophrenia.
    Cuesta MJ; Peralta V; Zarzuela A
    Psychol Rep; 1998 Dec; 83(3 Pt 1):895-8. PubMed ID: 9923164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Multi-referential approach to schizophrenia in daily institutional management].
    Hayat M
    Encephale; 1996 Oct; 22 Spec No 3():80-1. PubMed ID: 8954283
    [No Abstract]   [Full Text] [Related]  

  • 32. Associations of awareness of illness in schizophrenia spectrum disorder with social cognition and cognitive perceptual organization.
    Lysaker PH; Daroyanni P; Ringer JM; Beattie NL; Strasburger AM; Davis LW
    J Nerv Ment Dis; 2007 Jul; 195(7):618-21. PubMed ID: 17632254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A re-analysis of the relationship among coping, symptom severity and quality of life in schizophrenia.
    Martins J; Rudnick A
    Schizophr Res; 2007 Jan; 89(1-3):355-6. PubMed ID: 17029910
    [No Abstract]   [Full Text] [Related]  

  • 34. Is insight in schizophrenia multidimensional? Internal structure and associations of the Greek version of the Schedule for the Assessment of Insight-Expanded.
    Konstantakopoulos G; Ploumpidis D; Oulis P; Soumani A; Nikitopoulou S; Pappa K; Papadimitriou GN; David AS
    Psychiatry Res; 2013 Oct; 209(3):346-52. PubMed ID: 23489595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Awareness of being a patient and its relevance to insight into illness in patients with schizophrenia.
    Hayashi N; Yamashina M; Igarashi Y
    Compr Psychiatry; 1999; 40(5):377-85. PubMed ID: 10509621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life in schizophrenia: insight and subjective response to neuroleptics.
    Browne S; Garavan J; Gervin M; Roe M; Larkin C; O'Callaghan E
    J Nerv Ment Dis; 1998 Feb; 186(2):74-8. PubMed ID: 9484306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug compliance and health locus of control in schizophrenia].
    Combes C; Feral F
    Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder.
    Smith TE; Hull JW; Israel LM; Willson DF
    Schizophr Bull; 2000; 26(1):193-200. PubMed ID: 10755681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight, neurocognitive function and symptom clusters in chronic schizophrenia.
    Collins AA; Remington GJ; Coulter K; Birkett K
    Schizophr Res; 1997 Oct; 27(1):37-44. PubMed ID: 9373893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between insight, illness and treatment outcome in schizophrenia.
    Schwartz RC
    Psychiatr Q; 1998; 69(1):1-22. PubMed ID: 9536472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.